Specialized Bioconversion Manufacturing and R&D Biocompany
Secured high content of active ingredients using bioconversion technology from red ginseng (highest yield)
→ Compound K (yield over 90%)
→ Ginsenoside F1 (yield over 60%)
Secured simultaneous conversion technology of red ginseng compound K and ginsenoside F1 (only in the world)
→ Minimized chemical conversion (10% or less) / Maximized biological (strain) conversion (90% or more)
→ Papers (including SCI): 131, Patent registration: 52, Technology transfer: 8